| Market Cap | ₹2,269Cr |
| ROE | 9.16% |
| P/E Ratio(TTM) | 28.22 |
| EPS(TTM) | 24.78 |
| P/B Ratio | 2.46 |
| Dividend Yield | 0.39% |
| Industry P/E | 55.77 |
| Book Value | 284.52 |
| Debt to Equity | 0.31 |
| Face Value | 5 |
| Managing Director | Pallavi Bhatevara |
| Founded | 2010 |
| NSE Symbol | KRSNAA |
| FUND NAME | AUM(%) |
|---|---|
| Tata Small Cap Fund Direct Growth | 1.64% |
| Bandhan Small Cap Fund Direct Growth | 0.23% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 45.43 | ||
| Metropolis Healthcare | NA (0.00%) | 61.13 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 67.24 | ||
| Thyrocare Technologies | NA (0.00%) | 48.16 |